2024-07-22 Purchase | 2024-07-22 8:26 pm | Artiva Biotherapeutics Inc. | ARTV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner | 416,666 | $12 | $4,999,992 | 2,398,324 (Direct) | View |
2022-05-25 Sale | 2022-05-27 7:20 pm | Elevation Oncology Inc. | ELEV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner | 702,737 | $4.1236 | $2,897,806 | 1,905,430 (Direct) | View |
2022-05-13 Sale | 2022-05-17 5:12 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 131,650 | $10.45 | $1,375,564 | 2,155,930 (Direct) | View |
2022-05-10 Sale | 2022-05-12 8:47 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 160,901 | $10.39 | $1,671,824 | 2,287,580 (Direct) | View |
2022-05-05 Sale | 2022-05-09 6:58 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 86,677 | $10.37 | $898,921 | 2,448,481 (Direct) | View |
2022-05-02 Sale | 2022-05-04 7:30 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 270,675 | $10.38 | $2,809,332 | 2,535,158 (Direct) | View |
2022-04-27 Sale | 2022-04-29 5:50 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 190,026 | $10.38 | $1,972,579 | 2,805,833 (Direct) | View |
2022-04-22 Sale | 2022-04-26 6:40 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 129,781 | $10.39 | $1,347,796 | 2,995,859 (Direct) | View |
2022-04-19 Sale | 2022-04-21 8:54 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 547,734 | $10.41 | $5,700,491 | 3,125,640 (Direct) | View |
2021-10-22 Sale | 2021-10-26 4:35 pm | Metacrine Inc. | MTCR | venBio Global Strategic Fund L.P. venBio Global Strategic GP L.P. venBio Global Strategic GP Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 615,702 | $1.5087 | $928,902 | 2,443,421 (Direct) | View |
2021-10-25 Purchase | 2021-10-25 7:40 pm | Ventyx Biosciences Inc. | VTYX | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S See Remarks 10% Owner | 312,500 | $16 | $5,000,000 | 5,011,536 (Indirect Direct) | View |
2021-06-29 Purchase | 2021-07-01 5:27 pm | Elevation Oncology Inc. | ELEV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner | 625,000 | $16 | $10,000,000 | 2,608,167 (Direct) | View |
2021-04-27 Purchase | 2021-04-29 6:44 pm | IMPEL NEUROPHARMA INC | IMPL | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 450,000 | $15 | $6,750,000 | 2,759,791 (Direct) | View |
2020-09-18 Purchase | 2020-09-22 5:22 pm | Metacrine Inc. | MTCR | Adelman Robert J Director 10% Owner | 230,000 | $13 | $2,990,000 | 3,059,123 (Direct) | View |
2020-08-11 Purchase | 2020-08-12 9:00 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 200,000 | $15 | $3,000,000 | 3,673,374 (Direct) | View |
2020-07-21 Purchase | 2020-07-21 9:29 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Adelman Robert J venBio Global Strategic Fund L.P. venBio Global Strategic GP Ltd. venBio Global Strategic Fund II L.P. venBio Global Strategic GP L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. See Remarks 10% Owner | 853,000 | $19 | $16,207,000 | 5,829,542 (Indirect Direct) | View |
2020-07-01 Sale | 2020-07-06 7:00 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 116,467 | $34.4 | $4,006,537 | 3,033,552 (Indirect) | View |
2020-03-04 Sale | 2020-03-06 5:23 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 45,950 | $23.76 | $1,091,608 | 3,150,019 (Indirect) | View |
2020-02-28 Sale | 2020-03-03 5:52 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 21,798 | $22.63 | $493,310 | 3,195,969 (Indirect) | View |
2020-02-25 Sale | 2020-02-27 7:51 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 5,904 | $22.8 | $134,635 | 3,227,767 (Indirect) | View |
2020-02-10 Sale | 2020-02-12 5:56 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 10,026 | $27.07 | $271,399 | 3,233,671 (Indirect) | View |
2020-02-06 Sale | 2020-02-10 5:47 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 6,102 | $27.03 | $164,955 | 3,233,697 (Indirect) | View |
2020-02-04 Sale | 2020-02-06 4:06 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 82,339 | $25.77 | $2,121,726 | 3,239,799 (Indirect) | View |
2020-01-13 Sale | 2020-01-14 08:58 am | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 494,000 | $20.23 | $9,993,620 | 3,322,138 (Indirect) | View |
2020-01-08 Sale | 2020-01-10 4:06 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 15,677 | $19.86 | $311,355 | 3,816,138 (Indirect) | View |
2020-01-06 Sale | 2020-01-08 4:10 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 73,221 | $19.86 | $1,454,530 | 3,831,815 (Indirect) | View |
2020-01-02 Sale | 2020-01-06 4:07 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 35,498 | $19.71 | $699,721 | 3,905,036 (Indirect) | View |
2019-12-31 Sale | 2020-01-03 4:13 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 14,324 | $23.96 | $343,259 | 3,940,534 (Indirect) | View |